Power Law company profile

Kura Oncology

Biotech & Life Sciences · San Diego, United States · Founded 2014 · IPO 2015 Colt

A clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers

Valuation

$137M

Market cap · May/2026

Revenue

$67M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Kura Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Avoro Capital Advisors

Foresite Capital

Suvretta Capital Management

Osage University Partners

ARCH Venture Partners

Nextech Invest

EcoR1 Capital

Global footprint

Where Kura Oncology has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States54.8%

🇮🇳 India23.5%

🇬🇧 United Kingdom6.5%

🇲🇽 Mexico5.7%

🇪🇸 Spain3.9%

Top 5 markets shown

Market sentiment

What the market is saying about Kura Oncology

An AI-synthesized read of the highest-engagement posts about Kura Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kura Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles